Literature DB >> 15072639

Pathways that elicit long-term changes in gene expression in nociceptive neurons following nerve injury: contributions to neuropathic pain.

Ying-Ju Sung1, Richard T Ambron.   

Abstract

Chronic neuropathic pain following nerve injury or inflammation is mediated by transcription-dependent changes in neurons that comprise the nociceptive pathway. Among these changes is often a long-term hyperexcitability (LTH) in primary nociceptors that persists long after the lesion has healed. LTH is manifest by a reduction in threshold and an increased tendency to fire action potentials. This increased excitability activates higher order neurons in the pathway, leading to the perception of pain. Efforts to ameliorate chronic pain would therefore benefit if we understood how LTH is induced, but studies toward this goal are impeded by the complexity and heterogeneity of vertebrate nervous systems. Fortunately, LTH is an evolutionarily conserved mechanism that underlies defensive behaviors across phyla, including invertebrates. Thus, the same electrophysiological changes that underlie LTH in vertebrate nociceptive neurons are seen in their counterparts in the experimentally favorable mollusk Aplysia californica. Nociceptive neurons of Aplysia are readily accessible and large enough to approach using a variety of cell and molecular approaches not possible in higher organisms. Studies of the molecular cascades activated by injury to Aplysia peripheral nerves has focused on a group of positive injury signals that are retrogradely transported from the injury site in the axon to the cell nucleus where they regulate gene transcription. One of these, protein kinase G, is activated by nitric oxide synthetase and its activation in axons is required for the induction of LTH after injury. This pathway, and the transcriptional events that it activates, are targets for therapeutic intervention for chronic pain.

Entities:  

Mesh:

Year:  2004        PMID: 15072639     DOI: 10.1179/016164104225013761

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  9 in total

Review 1.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

2.  Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin.

Authors:  Gary J Patti; Oscar Yanes; Leah P Shriver; Jean-Phillipe Courade; Ralf Tautenhahn; Marianne Manchester; Gary Siuzdak
Journal:  Nat Chem Biol       Date:  2012-01-22       Impact factor: 15.040

Review 3.  The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.

Authors:  Ryan A Mischel; Karan H Muchhala; William L Dewey; Hamid I Akbarali
Journal:  J Pain       Date:  2019-12-11       Impact factor: 5.820

Review 4.  Molluscan memory of injury: evolutionary insights into chronic pain and neurological disorders.

Authors:  Edgar T Walters; Leonid L Moroz
Journal:  Brain Behav Evol       Date:  2009-12-21       Impact factor: 1.808

5.  Extremely low frequency electromagnetic fields activate the ERK cascade, increase hsp70 protein levels and promote regeneration in Planaria.

Authors:  Reba Goodman; Avary Lin-Ye; Matthew S Geddis; Priya J Wickramaratne; Susan E Hodge; Spiro P Pantazatos; Martin Blank; Richard T Ambron
Journal:  Int J Radiat Biol       Date:  2009       Impact factor: 2.694

6.  Effects of axotomy on cultured sensory neurons of Aplysia: long-term injury-induced changes in excitability and morphology are mediated by different signaling pathways.

Authors:  Supinder S Bedi; Diancai Cai; David L Glanzman
Journal:  J Neurophysiol       Date:  2008-10-08       Impact factor: 2.714

7.  Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells.

Authors:  Michael S Thomas; Wenru Zhang; Paivi M Jordan; H Uri Saragovi; Giulio Taglialatela
Journal:  J Neuroinflammation       Date:  2005-09-06       Impact factor: 8.322

8.  Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome.

Authors:  Cristina Piras; Bruno Maria Pintus; Antonio Noto; Maurizio Evangelista; Vassilios Fanos; Mario Musu; Michele Mussap; Luigi Atzori; Salvatore Sardo; Gabriele Finco
Journal:  J Pain Res       Date:  2022-03-11       Impact factor: 3.133

9.  A novel inhibitor of active protein kinase G attenuates chronic inflammatory and osteoarthritic pain.

Authors:  Ying-Ju Sung; Nelson Sofoluke; Mary Nkamany; Shixian Deng; Yuli Xie; Jeremy Greenwood; Ramy Farid; Donald W Landry; Richard T Ambron
Journal:  Pain       Date:  2017-05       Impact factor: 7.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.